搜索临床试验以:分次首次剂量利妥昔单抗
总计173个结果
-
Joris B.W. ElbersErasmus Medical Center; HollandPTC招聘中
-
Universitaire Ziekenhuizen KU LeuvenMerck KGaA, Darmstadt, Germany完全的
-
BioSyngen Pte LtdThe First Affiliated Hospital of Zhengzhou University招聘中
-
National Research Council, SpainUniversidad Católica San Antonio de Murcia; The Scientific and Technological Research Council...完全的
-
Genuine Research Center, EgyptHorus Pharma完全的
-
Bangkok Metropolitan Administration Medical College...完全的
-
Cellectar Biosciences, Inc.招聘中多发性骨髓瘤 | 华氏巨球蛋白血症 | 套细胞淋巴瘤 | 边缘区淋巴瘤 | 慢性淋巴细胞白血病 | 淋巴浆细胞性淋巴瘤 | 弥漫性大 B 细胞淋巴瘤 | 小淋巴细胞淋巴瘤 | 中枢神经系统淋巴瘤美国, 澳大利亚, 捷克语, 希腊, 以色列, 巴西, 芬兰, 法国, 西班牙, 火鸡, 英国
-
SciensanoInstitute of Tropical Medicine, Belgium; Erasme University Hospital; Mensura EDPB完全的
-
University of Miami终止头颈癌 | 复发性疾病 | 鳞状细胞癌美国
-
Murdoch Childrens Research InstituteSydney Children's Hospitals Network; Royal Children's Hospital; Monash Health; Royal Hospital For...尚未招聘
-
Amsterdam UMC, location VUmcRadboud University Medical Center; University Medical Center Groningen终止
-
Genuine Research Center, EgyptEva Pharma完全的
-
University of Heidelberg Medical CenteriOMEDICO AG完全的
-
Genuine Research Center, EgyptMinaPharm Pharmaceuticals完全的
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)完全的
-
Genuine Research Center, EgyptMagic Pharma, Egypt完全的
-
Rajaie Cardiovascular Medical and Research CenterBrigham and Women's Hospital; Tehran Heart Center; Imam Khomeini Hospital; Masih Daneshvari Hospital 和其他合作者完全的
-
Gruppo Italiano Terapie Innovative nei Linfomi完全的
-
Genuine Research Center, EgyptAl-debeiky pharma完全的
-
Robert F. JamesIndiana University School of Medicine暂停
-
University of Arkansas撤销
-
Innovent Biologics (Suzhou) Co. Ltd.完全的
-
Genuine Research Center, EgyptMagic Pharma, Egypt完全的
-
Hellenic Oncology Research Group终止
-
FENG Ji-fengChinese Anti-Cancer Association未知